PMID- 15336377 OWN - NLM STAT- MEDLINE DCOM- 20050301 LR - 20191210 IS - 0731-7085 (Print) IS - 0731-7085 (Linking) VI - 35 IP - 5 DP - 2004 Sep 3 TI - Simultaneous determination of serum flecainide and its metabolites by using high performance liquid chromatography. PG - 1307-12 AB - Simultaneous determination of serum flecainide and its oxidative metabolites was carried out by using high performance liquid chromatography (HPLC) equipped with conventional octadecylsilyl silica (ODS) column and fluorescence detector. Flecainide and its metabolites, m-O-dealkylated flecainide (MODF) and m-O-dealkylated lactam of flecainide (MODLF) in serum were extracted with ethyl acetate. The recoveries of flecainide, MODF and MODLF were greater than 92, 93, and 60% with the coefficient of variations (CVs) less than 3.2, 5.8, and 5.3%, respectively. The calibration curves were linear at the concentration range of 50-1500 ng/mL for flecainide and 10-500 ng/mL for MODF and MODLF (r > 0.999). The CVs for intra-day assay were 2.7-5.3% for flecainide, 3.0-4.2% for MODF, and 3.7-4.3% for MODLF, respectively. The CVs for inter-day assay were 7.0-8.4% for flecainide, 3.3-6.7% for MODF, and 4.4-7.7% for MODLF, respectively. This assay method can be used for assessing the metabolic ability of flecainide in the patients with tachyarrhythmia. FAU - Doki, Kosuke AU - Doki K AD - Department of Pharmaceutical Sciences, Institute of Clinical Medicine, University of Tsukuba, Ten-nodai 1-1-1, Tsukuba, Ibaraki 305-8575, Japan. FAU - Homma, Masato AU - Homma M FAU - Kuga, Keisuke AU - Kuga K FAU - Watanabe, Shigeyuki AU - Watanabe S FAU - Yamaguchi, Iwao AU - Yamaguchi I FAU - Kohda, Yukinao AU - Kohda Y LA - eng PT - Journal Article PT - Validation Study PL - England TA - J Pharm Biomed Anal JT - Journal of pharmaceutical and biomedical analysis JID - 8309336 RN - 0 (Anti-Arrhythmia Agents) RN - K94FTS1806 (Flecainide) SB - IM MH - Adult MH - Anti-Arrhythmia Agents/blood MH - Chromatography, High Pressure Liquid/instrumentation MH - Female MH - Flecainide/analogs & derivatives/*blood/pharmacokinetics MH - Humans MH - Male MH - Molecular Structure MH - Reproducibility of Results MH - Sensitivity and Specificity EDAT- 2004/09/01 05:00 MHDA- 2005/03/02 09:00 CRDT- 2004/09/01 05:00 PHST- 2004/03/09 00:00 [received] PHST- 2004/04/13 00:00 [revised] PHST- 2004/04/19 00:00 [accepted] PHST- 2004/09/01 05:00 [pubmed] PHST- 2005/03/02 09:00 [medline] PHST- 2004/09/01 05:00 [entrez] AID - S0731708504001888 [pii] AID - 10.1016/j.jpba.2004.04.009 [doi] PST - ppublish SO - J Pharm Biomed Anal. 2004 Sep 3;35(5):1307-12. doi: 10.1016/j.jpba.2004.04.009.